Literature DB >> 1442992

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.

J M Wheeler1, J D Knittle, J D Miller.   

Abstract

OBJECTIVE: We aimed to assess the efficacy of depot leuprolide versus danazol in the treatment of endometriosis. STUDY
DESIGN: A double-blind randomized trial of 270 patients from 22 centers compared the pretreatment and posttreatment laparoscopic extent of endometriosis. Pretreatment and posttreatment endometriosis symptoms and signs were assessed with standardized methods.
RESULTS: When compared with danazol, leuprolide depot caused a more rapid and profound suppression of estradiol. Leuprolide depot and danazol were similarly efficacious in decreasing the extent of endometriosis, as well as the pain and tenderness associated with endometriosis.
CONCLUSION: Depot leuprolide is an effective alternative to danazol in decreasing the extent of endometriosis and endometriosis-related pain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442992     DOI: 10.1016/s0002-9378(11)91718-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Current and Emerging Therapeutics for the Management of Endometriosis.

Authors:  Simone Ferrero; Fabio Barra; Umberto Leone Roberti Maggiore
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

2.  Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.

Authors:  Kazuya Makita; Ken Ishitani; Hiroaki Ohta; Fumi Horiguchi; Shiro Nozawa
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 3.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

Review 4.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 5.  Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.

Authors:  M Sagsveen; J E Farmer; A Prentice; A Breeze
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 6.  Ovulation suppression for endometriosis.

Authors:  E Hughes; J Brown; J J Collins; C Farquhar; D M Fedorkow; P Vandekerckhove
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

7.  The success of laser laparoscopy in the treatment of endometriosis: a two-step analysis.

Authors:  J D Paulson; R Borremeo; G Speck
Journal:  JSLS       Date:  2001 Jan-Mar       Impact factor: 2.172

8.  Delayed oral estradiol combined with leuprolide increases endometriosis-related pain.

Authors:  B S Hurst; S C Gardner; K E Tucker; C A Awoniyi; W D Schlaff
Journal:  JSLS       Date:  2000 Apr-Jun       Impact factor: 2.172

Review 9.  Reevaluating response and failure of medical treatment of endometriosis: a systematic review.

Authors:  Christian M Becker; William T Gattrell; Kerstin Gude; Sukhbir S Singh
Journal:  Fertil Steril       Date:  2017-07       Impact factor: 7.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.